At the news
? NEUTRALIMPACT 3/10 PRESS-RELEASE filed Mar 19, 2026 at 07:00 ET
NRx Pharmaceuticals announced it will host a conference call to discuss its fiscal year 2025 financial results and provide updates on its drug development programs, including NRX-100 and NRX-101. The press release contains no actual financial data, only forward-looking statements and procedural details about the earnings call.
- NRx Pharmaceuticals will host an earnings call on March 24, 2026, to discuss FY2025 results.
- No financial figures (revenue, EPS, etc.) were disclosed in the press release.
- Company highlighted progress in drug development programs and regulatory designations for NRX-100 and NRX-101.
- Forward-looking statements dominate the release; no material financial or operational data provided.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access